Challenging regulatory drug-drug interaction guideline on the 1% reportable limit for plasma-protein binding

Niosi Mark; Riccardi Keith; Yates Phillip; Cawley Shannon; Chang Cheng; Funk Carrie; Lin Jian; Di Li

首页> 外文期刊>Drug Metabolism Reviews >Challenging regulatory drug-drug interaction guideline on the 1% reportable limit for plasma-protein binding

【24h】

Challenging regulatory drug-drug interaction guideline on the 1% reportable limit for plasma-protein binding

机译：具有挑战性的药物-药物相互作用指导原则要求血浆蛋白结合的可报告极限为1％

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Drug Metabolism Reviews》 |2016年第4期|共1页
作者
Niosi Mark; Riccardi Keith; Yates Phillip; Cawley Shannon; Chang Cheng; Funk Carrie; Lin Jian; Di Li;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类药理学;
关键词

相似文献

外文文献
中文文献
专利

1. Challenging regulatory drug-drug interaction guideline on the 1% reportable limit for plasma-protein binding [J] . Niosi Mark, Riccardi Keith, Yates Phillip, Drug Metabolism Reviews . 2016,第1a4期

机译：具有挑战性的药物-药物相互作用指导原则要求血浆蛋白结合的可报告极限为1％
2. Challenging regulatory drug-drug interaction guideline on the 1% reportable limit for plasma-protein binding [J] . Niosi Mark, Riccardi Keith, Yates Phillip, Drug Metabolism Reviews . 2016,第1a4期

机译：具有挑战性的药物-药物相互作用指导原则要求血浆蛋白结合的可报告极限为1％
3. Challenging regulatory drug-drug interaction guideline on the 1% reportable limit for plasma-protein binding [J] . Niosi Mark, Riccardi Keith, Yates Phillip, Drug Metabolism Reviews . 2016,第1a4期

机译：对血浆蛋白结合的1％报告限额的挑战性调节药物互动指南
4. Drug-Drug Interaction Signal Detection from Drug Safety Reports [C] . Brian Zylich, Brian McCarthy, Andrew Schade, IEEE MIT Undergraduate Research Technology Conference . 2018

机译：药物安全报告中的药物相互作用信号检测
5. Clinical Significance and Regulatory Framework for the Evaluation of Organic Anion Transporting Polypeptide 1B-Based Drug-Drug Interactions [D] . McFeely, Savannah Jane Kerr. 2019

机译：用于评价有机阴离子输送多肽1B基药物相互作用的临床意义和监管框架
6. Assessment of the cardiovascular adverse effects of drug-drug interactions through a combined analysis of spontaneous reports and predicted drug-target interactions [O] . Sergey Ivanov, Alexey Lagunin, Dmitry Filimonov, 2019

机译：通过对自发报告和预测的药物-靶标相互作用的综合分析评估药物-药物相互作用的心血管不良反应
7. Assessment of the cardiovascular adverse effects of drug-drug interactions through a combined analysis of spontaneous reports and predicted drug-target interactions [O] . Sergey Ivanov, Alexey Lagunin, Dmitry Filimonov, 2019

机译：通过自发报告的组合分析评估药物 - 药物相互作用的心血管不良影响和预测的药物 - 目标相互作用
8. Neutron and x-ray scattering studies of the interactions between Ca2+-binding proteins and their regulatory targets: Comparisons of troponin C and calmodulin. [R] . Trewhella, J., Olah, G. A. 1993

机译：中子和X射线散射研究Ca2 +结合蛋白与其调节靶标之间的相互作用：肌钙蛋白C和钙调蛋白的比较。

Challenging regulatory drug-drug interaction guideline on the 1% reportable limit for plasma-protein binding

著录项

相似文献

相关主题

期刊订阅